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ABBREVIATIONS 
AD, acidic trans activating domain; ASC, apoptotic speck protein; BIR, baculovirus inhibitor 
repeat domain; CARD, caspase recruitment domain; DD, death domain; DED, death effector 
domain; HD1, helix domain 1; RMSD root-mean-square deviation; LRR, leucine-rich repeats; 
MAVS, mitochondrial antiviral signaling protein; NBD, nucleotide binding domain; NLR, 
nucleotide-binding domain and leucine-rich repeat-containing proteins; NMR, nuclear 
magnetic resonance; NOD, nucleotide oligomerization domain; PAMP, pathogen associated 
molecular pattern; PYD, pyrin domain; PRR, pattern recognition receptor; RIG-I, retinoic 
acid-inducible gene I; RIPK, receptor-interacting serine/threonine-protein kinase; TRAF, 
TNF receptor associated factor; WHD, winged helix domain. 
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ABSTRACT 
The cytosolic nucleotide-binding domain and leucine-rich repeat-containing receptors (NLRs) 
are key sensors for bacterial and viral invaders and endogenous stress signals. NLRs contain a 
varying N-terminal effector domain that regulates the downstream signaling events upon its 
activation and determines the subclass to which a NLR member belongs. NLRC5 contains an 
unclassified N-terminal effector domain that has been reported to interact downstream with 
the tandem CARD of RIG-I. Here we report the solution structure of the N-terminal effector 
domain of NLRC5 and in vitro interaction experiments with the tandem CARD of RIG-I. The 
N-terminal effector domain of NLRC5 adopts a six α-helix bundle with a general death fold, 
though it displays specific structural features that are strikingly different from the CARD.  
Notably, α-helix 3 is replaced by an ordered loop and α-helix 1 is devoid of the characteristic 
interruption. Detailed structural alignments between the N-terminal effector domains of 
NLRC5 with a representative of each death-fold subfamily showed that NLRC5 fits best to 
the CARD subfamily and can be called an atypical CARD. Due to the specific structural 
features the atypical CARD also displays a different electrostatic surface. As the shape and 
charge of the surface is crucial for the establishment of a homotypic CARD-CARD 
interaction, these specific structural features seem to have a significant effect on the 
interaction between the atypical CARD of NLRC5 and the tandem RIG-I CARD. 
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Vertebrates have developed different strategies within the innate and adaptive immune 
system to defend themselves against a plethora of environmental pathogens. The innate 
immune system provides the first barrier of defense and contains the class of pattern 
recognition receptors (PRRs), which are responsible for the detection of pathogens and the 
following immune response(s). PRRs recognize a pathogen-associated molecular pattern 
(PAMP) or damage-associated molecular pattern (DAMP) to induce a signaling cascade that 
results in an inflammatory or antiviral immune response specific for the molecular pattern. 
The importance of the PRR regulatory activities in the immune system is shown by numerous 
human auto-inflammatory and immune disorders related to impaired activities of PRR family 
members12.  
PRRs contain four different subfamilies that can be divided into membrane-bound and 
cytoplasmic receptors3. The group of nucleotide-binding domain and leucine-rich repeat 
containing (NLR) receptors is a subfamily that is active in the cytoplasm and characterized by 
their tripartite domain architecture. This subfamily contains an N-terminal effector domain, 
linking the NLR to a downstream signaling cascade; a central nucleotide-binding 
oligomerization domain (NOD) module responsible for oligomerization, comprising the 
nucleotide-binding domain (NBD), the helical domain HD1, and the winged-helix domain 
(WHD)4; and a C-terminal leucine-rich repeat (LRR), responsible for ligand binding5. The 
NLRs are further divided into subclasses based on their N-terminal effector domain: the 
NLRA subclass containing an acidic trans-activating domain (AD), the NLRB subclass 
containing a baculovirus inhibitor repeat domain (BIR), the NLRC subclass with a caspase 
recruitment domain (CARD), and the NLRP subclass containing a pyrin domain (PYD)5.  
The NLR (sub) family members containing a CARD (NLRC) perform different immune 
regulatory functions. Upon activation by the protein flagellin, NLRC4 sequentially recruits 
the adaptor protein ASC and procaspase-1 forming the NLRC4 inflammasome.  
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This NLRC4 inflammasome activates caspase-1 and finally initiates a pro-inflammatory 
response by inducing interleukin-1β and interleukin-18 activation6. NLRC1 and NLRC2 seem 
to function without the formation of an inflammasome. When triggered by specific 
peptidoglycan fragments from the bacterial cell wall, NLRC1 and NLRC2 interact with the 
receptor-interacting serine/threonine-protein kinase (RIPK) 2 through a homotypic CARD-
CARD interaction7. RIPK2 triggers the canonical NF-κB and MAPK pathways to initiate 
several responses, such as the production of pro-inflammatory cytokines8,9. NLRC3 has been 
implicated to modulate the TNF receptor associated factor 6 (TRAF6) activity under non-
inflammatory conditions10. In contrast to other NLRC members, NLRC5 seems to execute 
two different functions: as a transactivator of MHC class I transcription in immune cells11,12 
and as a regulator of immune responses triggered by specific PAMPs13,14.  
As a transactivator, NLRC5 interacts with transcription factors bound to a conserved 
W/SXY motif at the promoter region of MHC class I to form a multiprotein complex, upon 
stimulation with interferon-γ (IFN-γ).  This multiprotein complex is called the NLRC5 
enhanceosome and induces MHC class I expression11,12,15. 
As a regulator of innate immune responses NLRC5 has been linked to NLRP314 and RIG-
I/MDA513. However, this role remains controversial or unclear as contradictory results have 
been reported. In transfected human monocytes, stimulated with specific PAMPs and 
DAMPs, it was shown that NLRC5 is required for NLRP3 inflammasome activation and that 
it interacts with NLRP3 and the apoptotic speck protein (ASC)14. However, this result was not 
supported by overexpression experiments in macrophages in which NLRC5 was shown to be 
dispensable for a NLRP3 inflammasome response16. Others reported NLRC5 to be a negative 
regulator of an antiviral response and type I interferon production13. As a negative regulator, 
NLRC5 binds IKKα/IKKβ and inhibits their activation and thus the antiviral response.  
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In mouse macrophages, NLRC5 interacts with the N-terminal tandem CARD of retinoic 
acid-inducible gene I (RIG-I) and blocks its binding to mitochondrial antiviral signaling 
protein (MAVS), therefore inhibiting IFN-β signaling13.  
NLRC5 contains a domain architecture that is characteristic for NLR proteins. In immune 
signaling the N-terminal effector domain generally determines which signaling cascade is 
triggered through a homotypic interaction with its ligand. Sequence alignments show that the 
N-terminal effector domain of NLRC5 is different from other death-fold domains. For that 
reason the N-terminal effector domain of NLRC5 has been named an atypical death domain 
or a CARD17, 18. The CARD family of proteins belongs to the death-fold superfamily which 
includes the aforementioned PYD, the death domain (DD) and the death effector domain 
(DED)family19. These domains all arrange in an antiparallel α-helical bundle displaying a 
Greek key topology.   
Because of the particular sequence properties and difficulties to classify the NLRC5 N-
terminal effector domain, we decided to determine its three dimensional structure. Since the 
role of NLRC5 in immune regulation is still unclear this structure, together with biochemical 
interaction experiments might help in finding its cellular binding partner(s) in immune 
regulation and in innate immune responses. We describe the structure and backbone dynamics 
of the mouse NLRC5 N-terminal effector domain. The effector domain possesses a fold 
similar to the one of the death-fold domains; however, it displays significant differences in the 
number of core α-helices and their relative orientation. We show here that the N-terminal 
effector domain of NLRC5 fits best to the CARD subfamily and is therefore called an atypical 
CARD. We also present in vitro binding experiments to test a previously published 
interaction between the tandem CARD of RIG-I and NLRC513.  
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MATERIALS AND METHODS 
Cloning and Expression  
Mouse NLRC5 atypical CARD coding for residues 1 to 96 and residues 1 to 147 was 
amplified with standard PCR methods and subsequently cloned into the pGEX-6p1 vector 
(GE Healthcare) using the BamHI (5’) and XhoI (3’) restriction sites. As a result, a 
glutathione S-transferase (GST) tag, together with a human rhinovirus 3C protease (GE 
healthcare) cleavage site was added to the N-terminus of the mouse NLRC5 atypical CARD. 
All molecular cloning was performed with standard PCR methods. Transformed Escherichia 
coli Bl21(DE3) cells were grown in M9 minimal medium supplemented with either 15NH4Cl 
(Sigma-Aldrich) or 15NH4Cl and 13C6 d-Glucose (Sigma-Aldrich) as the sole sources of 
nitrogen and carbon for the 15N-labeled and the 15N, 13C-labeled mouse NLRC5 atypical 
CARD, respectively. Overexpression was induced at OD600 between 0.6 – 0.8 with 0.5 mM 
isopropyl-D-thiol galactosidase (IPTG, Biosolve) and continued for 13 to 16 hours at 30°C.  
Mouse RIG-I tandem CARD (residues 1 to 186) was cloned into a modified pBAD24 
expression vector with FX cloning20, adding a human rhinovirus 3C protease (GE healthcare) 
cleavage site, a eGFP-tag, and decahistidine affinity tag to the C-terminus. Transformed 
Escherichia coli MC1061 cells were grown in LB medium at 37°C until an OD600 between 0.6 
– 0.8 was reached. The expression of the RIG-I 1-186 fusion protein was induced with 2 x10-2 
% of L-arabinose (Sigma-Aldrich) and continued for 16 to 19 hours at 18°C.  
 
  
8 
 
Protein Purification  
Escherichia coli Bl21(DE3) cells containing the overexpressed mouse atypical CARD of 
NLRC5 (1-96 and 1-147) were resuspended in lysis buffer (50 mM sodium phosphate pH 7.3, 
100 mM NaCl, 50 mM KCl, 1 mM EDTA, 0.5 mM Tris(2-carboxyethyl)phosphine (TCEP, 
Acros) and Complete Protease Inhibitor (Roche)) and subsequently lysed using the 
Emulsiflex C3 (Avestin). The cell lysate was centrifuged at 13,000 rpm for 45 min. at 4°C, 
filtered (0.45 µm) and applied to an equilibrated 5 ml Protino GST/4B column (Macherey 
Nagel). The Protino GST/4B column was subsequently washed with 20 column volumes of 
lysis buffer. To remove the GST-tag, human rhinovirus 3C protease (GE Healthcare) was 
diluted to a molecular ratio of 1:20 and applied to the Protino GST/4B column. The column 
was incubated overnight (13 to 16 hours) at 4°C. A pre-equilibrated 1 ml GST FF column 
(GE Healthcare) was attached to the elution end of the Protino GST/4B, and the mouse 
NLRC5 atypical CARD alone was eluted by applying five column volumes of lysis buffer. 
The eluted atypical CARD of mouse NLRC5 comprising residues 1 to 96 was further purified 
to homogeneity in 20 mM Mes pH 6.2, 100 mM NaCl, 50 mM KCl, and 2 mM TCEP by size-
exclusion chromatography using a superdex S75 10/300 (GE Healthcare).  
The eluted NLRC5 comprising residues 1 to 147 was first subjected to overnight dialysis at 
4°C with the ion exchange buffer (50 mM Tris pH 9, 10% glycerol) before it was applied to a 
5 ml ResourceQ column anion exchanger (GE healthcare) and purified with a NaCl gradient.  
The eluted atypical CARD of mouse NLRC5 comprising residues 1 to 147 was further 
purified to homogeneity in 20 mM sodium phosphate pH 7.5, 60 mM NaCl, and 40 mM KCl 
by size-exclusion chromatography using a superdex S75 10/300 (GE Healthcare). Both 
proteins were concentrated to approximately 0.6 mM for NMR experiments.  
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MC1061 cells containing the overexpressed tandem CARD of mouse RIG-I were 
resuspended in lysis buffer (50 mM sodium phosphate pH 8, 300 mM NaCl, 10 mM 
Imidazole, and Complete Protease Inhibitor EDTA free (Roche)) and subsequently lysed 
using the Emulsiflex C3 (Avestin). The cell lysate was centrifuged at 13,000 rpm for 45 min. 
at 4°C, filtered (0.45 um), and applied to equilibrated Protino Ni-NTA agarose (Macherey 
Nagel). The Protino Ni-NTA agarose was subsequently washed with 100 column volumes of 
lysis buffer before it was eluted in elution buffer (20 mM sodium phosphate pH 8, 300 mM 
NaCl, 300 mM Imidazole). The eGFP and decahistidine affinity tag were removed by adding 
human rhinovirus 3C protease (GE Healthcare) to a molecular ratio of 1:20 to mouse RIG-I 
tandem CARD. Cleavage was performed in a dialysis membrane (MWCO: 12 – 14 kDa, 
Spectrumlabs) and dialyzed overnight (13 to 16 hours) at 4°C against the size exclusion 
chromatography buffer (10 mM Hepes pH 7.4, 150 mM NaCl, 0.5 mM TCEP). After 
cleavage, the fusion tags were removed by incubating it with equilibrated Protino Ni-NTA 
agarose. The mouse RIG-I tandem CARD was further purified to homogeneity in size-
exclusion chromatography buffer using a superdex S75 10/300 (GE Healthcare). 
 
NMR Spectroscopy 
Human NLRC5 constructs 1-103, 1-111, 1-133, and mouse NLRC5 constructs 1-96 and 1-
130 were all subjected to crystallization trials, but none resulted in crystals. For that reason 
we used NMR spectroscopy to determine the structure. [15N, 1H]-HSQC spectra of mouse 
NLRC5 constructs encoding residues 1-96 and 1-147 were initially compared to select for the 
most suitable construct. While only a subset of all expected peaks was observed in the longer 
construct, most of the expected amide moieties were present in the 1-96 construct. 
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CD spectra revealed typical features of an α-helical protein, with a melting temperature 
around 66°C (Figure S1, supporting information). Accordingly, all NMR spectra for 
structural experiments were recorded at 310K, the NMR perturbation shift assays were 
recorded at 300K using Bruker Avance 600 and 700 MHz spectrometers equipped with 
cryogenically cooled triple-resonance probe heads. Spectra were processed with linear 
prediction in indirect frequency dimensions, generally applying cosine-bell window functions 
in the Bruker spectrometer software TOPSPIN 2.3 and transferred into the program CARA21 
for further analysis. Proton chemical shifts were calibrated from the positions of the water line 
at 4.63 ppm at 310K, from which the carbon and nitrogen scales were derived indirectly. All 
NMR experiments were taken from the Bruker pulse program library, and incorporated, 
whenever possible, the Kay-Rance sensitivity enhancements schemes and coherence 
selections using pulsed-field gradients. Sequence-specific resonance assignments were 
accomplished using established procedures. Initially, spin systems were picked in the [15N, 
1H]-HSQC spectrum. For the sequential backbone assignment, a series of triple resonance 
spectra were acquired on the uniformly [15N, 13C]-labeled atypical CARD of NLRC5 in 95% 
H2O/5% 2H2O. To link sequential amide moieties, CBCA(CO)NH22 and HNCACB23 spectra 
were recorded to match Cα/Cβ pairs. Carbonyl frequencies were linked using the recorded 
HNCO24 and HN(CA)CO25. The side-chains were assigned using HC(C)H-TOCSY/(H)CCH-
TOCSY experiments26, 27, starting from the assigned Cα/Cβ pairs. The proton frequencies 
within the aromatic spin systems were annotated using an [13C, 1H]-HSQC and 13C-resolved 
NOESY centered on aromatic carbons. The aromatic spin systems were linked to the aliphatic 
side-chains using CB(CGCD)HD spectra28 and aromatic spin systems were annotated with the 
help of a 1H-TOCSY-relayed ct-[13C, 1H]-HMQC experiment29. Backbone and side-chain 
assignment was performed with the software CARA21. In addition, torsion-angle restraints 
were derived from the backbone chemical shifts using TALOS30.  
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With the help of the ATNOS/CANDID protocol31, 32, UNIO’10 software automatically picked 
and assigned the 15N- and 13C-resolved NOESY signals.  
The peak lists were then automatically annotated by the AUTOASSIGN macro of CYANA 
3.033 and converted into upper-distance restraints. A total of 1278 upper-distance restraints 
were used to calculate the final structure using restrained torsion angle molecular dynamics as 
implemented in the program CYANA 3.033. The CYANA target function in the final run was 
1.5. The resulting coordinates for the structure of the atypical CARD of mouse NLRC5 were 
energy minimized in explicit water using the CHARMM force-field34. Of the initially 100 
calculated structures the 20 conformers with the lowest target function were used for energy 
minimization in CHARMM34 and for further structural analysis. PyMOL 
(http://www.pymol.org) was used to analyze the final 20 conformers and to create the figures 
presenting the molecular models. 15N-relaxation data were recorded using 600 and 150 µM 
samples on a  700 MHz spectrometer at 310K with proton-detected versions of the 15N{1H}-
steady-state NOE experiment35, the Carr-Purcell-Meiboom-Gill (R2)36, and the inversion-
recovery (R1)37 experiments. Relaxation dispersion was measured with the relaxation-
compensated CPMG dispersion experiment38 using eight different CPMG field strengths 
ranging from 31 to 455 Hz. Peak volumes were integrated within the program SPSCAN that 
uses lineshape-deconvolution of signals for proper integration of partially overlapping peaks, 
and evaluated using home-written routines for least-squares fitting. The relaxation data were 
analyzed in a model-free approach39, 40 using the software DYNAMICS41, 42, 43. ROTDIF44 was 
used to calculate the overall correlation time from the relaxation data. This value was 
subsequently used in the Modelfree analysis. The analysis revealed that a monomer-dimer 
equililibrium had to be assumed to fit the data. Different values of the dissociation constant 
Kd in the range between 10 µM and 900 µM were used resulting in different optimal 
correlation times τc. 
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Protein Data Bank (PDB) and Biological Magnetic Resonance Bank entry (BMRB) 
Assigned chemical shifts and coordinates were deposited in the PDB and BMRB databases 
under accesion codes 2MJM and 19732, respectivly. 
 
Chemical Shift Perturbation Assays 
Possible interactions between the atypical CARD of mouse NLRC5 and the tandem CARD 
of mouse RIG-I were probed by NMR using chemical shift perturbation assays45. Therein, 
spectra recorded on 70 µM solutions of 15N-NLRC5 were measured in the absence and 
presence of 140 µM of mouse RIG-I tandem CARD at 300K. These measurements were 
performed at either pH 6.2 (in 20 mM Mes, 100 mM NaCl, 50 mM KCl, and 2 mM TCEP) or 
at pH 7.4 (in 10 mM Hepes, 150 mM NaCl, and 2 mM TCEP). 
 
Plasmid Construction and Transient Expression in HEK293T Cells 
NLRC5 and RIG-I constructs were cloned into a pcDNA5/FRT-vector (Invitrogen) 
modified for FX-cloning20 and supplemented with a sequence encoding for C-terminal 
affinity tags, adding a Myc-tag (NLRC5) or a C-terminal FLAG-tag (RIG-I) to the C-
terminus. As an exception, full-length human NLRC5 was cloned into a pcDNA3 adding a C-
terminal SBP-Myc-tag or an eGFP-SBP-Myc-tag. NLRC5 and RIG-I plasmid constructs 
included mouse NLRC5, encoding residues 1-96 and 1-130 and denoted as mu96 and mu130, 
respectively; human NLRC5, encoding residues 1-96, 1-130, 1-550, and 1-1866 denoted as 
hu96, hu130, hu550, hu1866, and hu1866-eGFP, respectively;  mouse RIG-I, encoding 
residues 1-186, marked as muRIG-I 186; and human RIG-I, encoding residues 1-186 and 1-
925, marked as huRIG-I 186 and huRIG-I 925, respectively. All molecular cloning was 
performed with standard PCR methods in combination with FX cloning20.  
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HEK293T cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM: Sigma-
Aldrich) supplemented with 10% v/v fetal bovine serum (FBS; Sigma-Aldrich) and 1% 
penicillin/streptomycin (Sigma-Aldrich). The cells were maintained at 5% (vol/vol) CO2 at 
37°C. Expression plasmids were separately transfected in HEK293T cells using 
polyethylenimine (PEI, Sigma-Aldrich)46. 
 
Co-immunoprecipitation Assays 
For cell lysis, HEK293T cells were isolated from the culture medium by centrifugation (300 
x g, 3 min. , at room temperature), resuspended in lysis buffer (50 mM Tris pH 7.5, 150 mM 
NaCl, 1% Nonidet P-40 substitute (Fluka), and EDTA-free complete protease inhibitor 
(Roche)), and incubated on ice for 30 min. Subsequently, the cell extract was centrifuged at 
13’000 rpm for 30 minutes at 4°C, followed by the isolation of the cell lysate from the cell 
pellet. The cell lysates containing a Myc-tagged protein were subjected to a pre-cleaning step 
to remove proteins that bind unspecifically to the M2-affinity gel (Sigma-Aldrich). The cell 
lysate was added to 30 µl of sepharose 6B (Sigma-Aldrich) which was pre-equilibrated in 
lysis buffer, incubated at 4°C for 30 min. with light agitation and followed by the isolation of 
the cell lysate by centrifugation (1’000 x g, 5 min., at 4°C). The cell lysates containing 
FLAG-tagged protein were added to 25 µl of M2-affinity gel (Sigma-Aldrich) that was 
equilibrated in lysis buffer, followed by three rounds of washing with lysis buffer to remove 
unbound proteins. The pre-cleaned cell lysates that contained the Myc-tagged protein were 
then added to the FLAG-tagged proteins that were bound to the M2-affinity gel and incubated 
for 1 hour at 4°C with light agitation. The M2-affinity gel was centrifuged at 1’000 x g for 5 
minutes at 4°C and the supernatant was removed before the M2-affinity gel was subjected to 
4 rounds of washing with the lysis buffer. The FLAG-tagged proteins were subsequently 
eluted from the M2-affinty gel by adding 55 µl of 0.1 M glycine pH 3.5 for 10 minutes on ice.  
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The elution reaction was stopped by adding 10 µl of 1 M Tris pH 7.5, 1.5 M NaCl. The M2-
affinity gel was centrifuged at 1’000 x g for 5 minutes at 4°C to isolate the supernatant, before 
it was mixed with 15 µl of SDS-loading buffer and subjected to SDS-PAGE and western blot 
analysis.   
 
RESULTS 
Cloning, Expression, and Purification 
Constructs of the atypical CARD of human NLRC5 encoding for residues 1-103, 1-112, 
and 1-130 and the atypical CARD of mouse NLRC5 encoding for residues 1-96 and 1-147 all 
showed high levels of soluble expression. As the mouse constructs delivered the highest yield 
of soluble protein, we decided to focus on the atypical CARD of mouse NLRC5 comprising 
residues 1-96 and 1-147 for the structure determination with solution NMR. Mouse NLRC5 
(1-96), was purified to homogeneity at pH 6.2 (Figure S2, supporting information). The 
protein was stable for weeks after purification; however, signs of oligomerization were 
detected over this period at 37°C, room temperature, and 4°C. Addition of 2 mM of the 
reducing agent TCEP to the purification buffers prevented oligomerization, suggesting that 
oligomerization was induced by oxidation of surface-exposed cysteine residues through 
disulfide bond formation.  
 
Structure Determination of the Atypical CARD of NLRC5 
Based on [15N, 1H]-HSQC spectra, mouse NLRC5 construct encoding residues 1-96 was 
selected for three dimensional structure determination. While only a subset of all expected 
peaks was observed in the construct encoding for mouse NLRC5 residues 1 – 147 (data not 
shown), almost all expected amide moieties were present in the mouse NLRC5 residues 1-96 
construct.  
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Backbone and side-chain assignments for the atypical CARD of mouse NLRC5 could be 
completed to 94%. The missing assignments included residues Asn14, Asn15, Val86, Asp89 
and Met90 (Figure S3, supporting information). The five amino acid remnant at the N-
terminus that originates from the 3C cleavage site (GPLGS) was not included in the structure 
determination and further structural analysis. 
 
The NMR Structure of the Atypical CARD of Mouse NLRC5 
The structure of the atypical CARD of mouse NLRC5 consists of five defined α-helices 
(α1, 2, 4, 5, and 6) that are closely packed around a hydrophobic core. A sixth α-helix (α0) 
does not contribute to the hydrophobic core and a loop instead of an expected α-helix 
connects helices α2 and α4 in the core (Table 1, Figure 1A, B). The α-helices encompassing 
residues 9-12 (α0), 16-28 (α1), 30-40 (α2), 55-68 (α4), 70-84 (α5), and 91-95 (α6), are all 
arranged in an anti-parallel fashion and five are stabilized around a hydrophobic core, a 
feature that is common in death-fold domains. As shown in Figure 1C, the residues that form 
the hydrophobic core are Leu22 and Leu26, in α-helix 1; Leu33 and Leu37 in α-helix 2; Ile58, 
Leu62 and Leu65 in α-helix 4; and Trp73, Phe76, Ile77, Leu80, and Leu84 in α-helix 5. 
Supporting the hydrophobic core are Trp19 (α1), Trp32 (α2), Phe40 (α4) and Leu94 (α6). In 
addition, Ile97 at the C-terminus has direct contact to the hydrophobic core. Alpha-helix 0 
does not contribute to the hydrophobic core as it points away from the center and is 
positioned on the outer surface of α-helix 6.  This orientation is fixed by  a salt bridge 
between Asp7 and Lys74 (data not shown). Alpha-helices 1-2 and 4-5 are connected by short 
well-defined loops. In contrast, α-helix 1 and 6 are preceded by a loop which are 3 and 6 
amino acids long, respectively. These two loops contain amino acids for which no resonances 
were observed in the [15N, 1H]-HSQC spectrum (Asn14, Asn15, Asp89, Met90), indicating 
the presence of conformational and/or chemical exchange.  
16 
 
The most striking feature of the atypical CARD of mouse NLRC5 is the long loop 
comprising residues 41 – 54 that connects α-helix 2 and helix 4, from hereon called α2-α4 
loop (Figure 1A, B).  
Based on the 20 most energetically favorable structures this α2-α4 loop is ordered, but 
displays a higher flexibility than the helical segments contributing to the core structure.  
Indeed, comparison of the loop sequence with other helical sequences in the atypical CARD 
of mouse NLRC5 and death-fold domains revealed that it has a lower helical propensity (data 
not shown).  
Interestingly, the α2-α4 loop is only stabilized by a small number of hydrophobic residues, 
mainly at the start of the loop (Figure S4, supporting information). Leu41, the first residue of 
the loop, is in a hydrophobic contact with Leu37 (α2), Leu40 and L65 (α5). The hydrophobic 
interaction between Tyr50 and Val57 (α5) stabilizes the C-terminal part of the loop. The 
center of the α2-α4 loop seems not to be stabilized by any hydrophobic interactions as the 
hydrophobic side chains of Leu46 and Met44 are directed outwards and away from α-helix 2 
and 4. Mouse and human NLRC5 atypical CARD share a sequence identity and similarity of 
50% and 62%, respectivly. The non-similar residues are spread out over the entire sequence, 
and are mainly present in the helices. A sequence comparison for the α2-α4 loop reveals less 
hydrophilic (2 versus 5) and more hydrophobic residues (3 versus 1) in the mouse ortholog in 
comparison to the human ortholog.  
 
Structural Comparison with the Death-fold Superfamily 
The structures most similar to the atypical CARD of mouse NLRC5 as identified by the 
DALI-server47 are those of CARDs, as shown in Table 2.   
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These Z-score matches are lower than generally observed within a death-fold subfamily 
(e.g. CARMA1 CARD/Apaf-1 CARD, z-score=14.4; Apaf-1 CARD/ICEBERG CARD, Z-
score 11.1; NLRP3 PYD/ASC PYD, 13.8). In addition, the atypical CARD of mouse NLRC5 
is related to the other death-fold subfamilies with similar DALI-server statistics (Table 2). 
This comparison shows that the atypical CARD of mouse NLRC5 has structural features that 
are common to all four sub-families, features that are only similar to the CARD, DD, and 
PYD subfamily and features that are clearly different from any of the four subfamily folds.  
In order to classify the atypical CARD of mouse NLRC5 in the death-fold superfamily we 
performed a structural alignment with all four sub-families (DED, DD, CARD, and PYD) 
using the secondary structure matching (SSM) algorithm48 (Figure 2).  
As the spatial arrangement of the N-and C-termini of the death-fold domains within their 
subfamilies are very different in comparison to the core, we focused on the spatial 
arrangement of α-helices 2, 3, 4, and 5 of the death-fold domains to initially classify the 
atypical CARD of mouse NLRC5 into one of the four death-fold subfamilies, supported by 
the specific structural features of every death-fold subfamily49, 50, 51, 52.  
The structural alignments indeed revealed that the spatial arrangement of α-helices 2, 4 and 
5 (and the α2-α4 loop) of the atypical CARD of mouse NLRC5 is very similar to that of all 
death-fold domain structures, with only small differences in the relative tilt angles. This 
notion is supported by the fact that a large portion of the amino acids involved in the 
formation of the hydrophobic core in the death-fold domains are conserved in α-helices 2, 4 
and 5 of the atypical CARD of mouse NLRC5 (Figure 2A). The most striking difference in 
the atypical CARD of mouse NLRC5 in comparison to the death-fold domains is the absence 
of α-helix 3. The PYD subfamily is an exception, as the absence of α-helix 3 is a structural 
characteristic that is known from the NLRP1 PYD, and that is very similar to the loop region 
connecting α-helix 2 and 3 in all other PYD structures (Figure 2B)53.  
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However, the α2-α4 loop of the atypical CARD of mouse NLRC5 and that of the PYDs are 
different in length (e.g. 18 amino acids in NLRP1 PYD versus 13 amino acids in the atypical 
CARD of mouse NLRC5), as is the orientation relative to α-helix 2 and 4. As shown for 
NLRP7 PYD, α-helix 3 has a very different orientation in comparison to the α2-α4 loop of the 
atypical CARD of  mouse NLRC5 (Figure 2B). In addition, α-helix 4 in the PYD fold is 
shorter than in the atypical CARD of mouse NLRC5.  
In the comparison to the DED of PEA-15, α-helix 3 of the DED-fold shows similarities to 
α-helix 3 of NLRP7 PYD, hence a very different orientation in comparison to the α2-α4 loop 
of the atypical CARD of mouse NLRC5 (Figure 2C). In addition, the DED subfamily is 
characterized by the presence of a RxDL-motif that is absent in the atypical CARD of mouse 
NLRC519.  
The α2-α4 loop of the atypical CARD of mouse NLRC5 has a very similar direction as α-
helix 3 of the RAIDD DD (Figure 2D)19. However, α-helices 2 and 5 of the DD-fold do not 
align well with the α-helices 2 and 5 of the atypical CARD of mouse NLRC5, in contrast to 
the other death-fold domains.  
To summarize, based on the structural alignment of α-helices 2, 4, 5, and α-helix 3/loop α2-
α4, the atypical CARD of mouse NLRC5 displays the best fit with the CARD-fold (Figure 
2E). In the following, we provide a more detailed analysis of the CARD features. Besides the 
α2-α4 loop, the most dramatic difference between the atypical CARD of mouse NLRC5 and 
the general CARD-fold is the absence of the characteristic interruption in the first α-helix 
(Figure 2E and Figure 3A). As a result, α-helix 1a and 1b are directly joined in the atypical 
CARD of mouse NLRC5 into one helix (α1) that displays a similar orientation as helix 1b of 
the ICEBERG CARD. The atypical CARD of mouse NLRC5 contains an additional short 
helical segment preceding α-helix 1 (Figure 3A).  
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The ICEBERG CARD contains a α-helix 3 that has a very similar orientation as the α2-α4 
loop, while maintaining the strong alignment with α-helix 2 and 5 of the atypical CARD of 
mouse NLRC5 (Figure 3B, C). In addition, α-helix 4 of both domains have the same length, 
and with the exception of a small tilt in the N-terminal domain of NLRC5, align well. At the 
C-terminus of the CARD structures, α-helix 6 displays some variability in its orientation and 
length, and a characteristic short loop that connects α-helix 5 to α-helix 6. However, in the 
atypical CARD of mouse NLRC5, the short α-helix 6 is directed away from α-helix 5 due to 
an extended 6 amino acid long loop (Figure 3D).  
Based on these structural alignments, the atypical CARD of mouse NLRC5 resembles most 
but not all characteristics of the CARD-subfamily. Therefore, the N-terminal effector domain 
of mouse NLRC5 can indeed be called an atypical CARD. 
 
Backbone Dynamics Probed via 15N Relaxation 
To probe for internal backbone dynamics via 15N relaxation, we measured 15N T1, T2 and 
15N {1H}-NOE relaxation data at concentrations of 600 and 150 µM (Figure 4). The 15N 
{1H}-NOE relaxation data unambiguously demonstrate that most parts of the protein display a 
defined structure (Figure 4A).  
Furthermore, the 15N {1H}-NOE continuously increases from residues 1 to 17, indicating 
that the N-terminus is flexible. Moreover, the NOE drops for residues 40 to 57, reflecting the 
increased flexibility of the α2-α4 loop. Residues of all other loops do not display increased 
flexibility. Interestingly, the increased flexibility of the α2-α4 loop is picked up by the R2 but 
not by the R1 values (Figure 4B, C). In addition, no long-range NOEs to protons in the others 
part of the domain were observed for the α2-α4 loop (Figure S5, supporting information).  
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We noticed, however, strongly increased values of R2 for residues localized on the surface 
formed by α-helix 1, 6, and the loop connecting α-helix 5 and 6 due to contributions from 
exchange to the transverse relaxation rate (Figure 4C, E). Unfortunately, signals for residues 
1-15 were broadened so much in the 150 µM sample that we could not analyse data for those 
residues. Interestingly, the residues corresponding to increased R2 values form a large 
hydrophobic patch on the surface of the protein, suggesting that this surface patch acts as a 
dimerization interface (Figure 5A). Using a model-free approach we calculated a correlation 
time (τc) of 7.49 ns (600 MHz data) to 7.55 ns (700 MHz data) from the relaxation data of 
residues 21 to 39 and 57 to 79 for the data recorded at a concentration of 600 µM. This value 
is larger than expected for a polypeptide of 96 residues54, indicating that a transient formation 
of dimers is likely to occur at the 600 µM concentration used for the 15N relaxation 
experiments. A similar increase in overall correlation time was recently observed for the 
second CARD of human RIG-I55.  We noticed that better fits resulted and that less parameters 
were required when data were fitted to a dimer model. Using the 15N {1H}-NOE, R1 and R2 
data recorded at both 600 (Figure S6, supporting information) and 700 MHz  best results 
were obtained when using a dissociation constant of  100 µM and an overall correlation time 
of 4.0 ns for the monomer.  
A larger number of residues for which model 3, that requires S2, Rex and τloc, is needed in 
the monomer case can be fit with model 2 (S2 and Rex) in the dimer case. Fewer contributions 
from slow local motion are required at an increase of exchange-affected residues. Moreover, 
the number of residues for which no appropriate model can be found is significantly smaller.  
In general, reduced values for the order parameter S2 were observed for residues comprising 
the α2-α4 loop, confirming the increased flexibility within the loop (Figure 4D). In addition, 
the analysis indicates that several residues are affected by exchange (Figure 4E).  
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In order to assess whether exchange contributions are due to conformational exchange or 
due to a monomer-dimer equilibrium, the sample was diluted to a concentration of 150 µM, 
and all relaxation measurements were repeated (Figure 4A-C, red curves).  In general, a 
decrease in transverse relaxation rates was observed. At that concentration the fitted global 
correlation time was 5.96 and 5.71 ns for the 600 and 700 MHz data, respectively, still 
signifiantly higher than the expected approx. 4 ns. Accordingly, the Modelfree anaylsis was 
performed still using the monomer-dimer model (Figure 4F,G). With the exception of the N-
terminal 15 residues slightly smaller exchange contributions were required to model the 
observed relaxation rates (Figure 4G). 
To further investigate these exchange contributions, CPMG relaxation dispersion 
experiments have been measured.  
However, relatively poor, featureless dispersion profiles (Figure S7, supporting 
information) with a mostly flat, uniform slope were observed for most of the exchange 
affected residues, being typical for exchange in the fast regime, and an exchange rate that is 
much larger than the maximum CPMG pulse repetition rate (kex >> max(νcpmg)). In order to 
assess whether exchange contributions are due to conformational exchange or due to a 
monomer-dimer equilibrium, the sample was diluted to a concentration of 150 µM and the T2 
measurement were repeated (Figure 4C).  In general, a decrease in transverse relaxation rates 
was observed which is in agreement with the expectation that the population of dimeric or 
oligomeric species decreases. 
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Electrostatic Surface Charges of the NLRC5 Atypical CARD 
Probing the surface of the atypical CARD of NLRC5 showed that it has two putative 
interaction surfaces: the hydrophobic patch formed by α-helix 1, 6, and the loop connecting α-
helix 5 and 6 (Figure 5A) and a negatively charged surface patch comprising Glu31, Asp79, 
Glu83, and Asp85 (Figure 5B). If we compare this negatively charged surface patch to 
charged surfaces in other CARDs, it becomes clear that it lacks the distinct concave or convex 
shape that is responsible for the homotypic (type I and type III) CARD-CARD interactions 
(data not shown)56.  
In addition, the negatively charged surface patch of the mouse NLRC5 atypical CARD is 
not located on any of the surface patches that are known to be involved in the homotypic 
CARD-CARD interactions (type I and type III)56, 57 or the homotypic DD-DD interactions 
(type I, type II, and type III) (data not shown)19.  
Modelling a second monomer on the hydrophobic surface patch resulted in the model of an 
atypical mouse NLRC5 CARD dimer, creating a new negatively charged surface patch 
(residues Glu31, Glu83, and Asp85) as a putative interaction surface (Figure 5C, D).  
 
Co-immunoprecipitation Assays 
Cui et al. performed co-immunoprecipitation assays in which they showed that full-length 
human NLRC5 interacts with full-length human RIG-I and an isolated (tandem) CARD in 
HEK293T cells, indicating that both proteins interact through a homotypic CARD-CARD 
interaction13. To further characterize this interaction we created several truncations of both 
human and mouse isoforms of NLRC5 and RIG-I to conduct interaction assays using protein 
overexpressed in HEK293T cells.  
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To probe the interaction between the atypical CARD of NLRC5 and the RIG-I tandem 
CARD in in vitro co-immunoprecipitation assays, we used two constructs of mouse NLRC5 
(mu96 and mu130) and six constructs of human NLRC5 (hu96, hu130, hu550, hu1866, and 
hu1866-eGFP) in combination with either mouse RIG-I (mu186) or human (hu186, hu925) 
constructs. In contrast to Cui et al.13, all constructs were separately expressed in HEK293T 
cells and combined only after cell lysis for the in vitro co-immunoprecipitation assays. In 
none of these experiments it was possible to detect an interaction between RIG-I and the 
atypical CARDs of mouse and human NLRC5 (Figure S8, supporting information).  
 
NMR Chemical Shift Mapping 
Alternatively we have probed for NLRC5 – RIG-I interactions by chemical shift 
perturbation (CSP) assays. This assay contains only the two putatively interacting purified 
proteins, lacking any other cellular components.  
15N-1H correlation spectra of 70 µM 15N-labelled atypical CARD of mouse NLRC5 (1-96 
AA) in absence or presence of 140 µM purified mouse RIG-I tandem CARD (Figure S1, 
supporting information) were compared. The measurements at pH 6.2 and pH 7.4 displayed 
identical peak positions before and after the addition of RIG-I (1-186 AA).  This indicated 
that no direct interaction between the atypical CARD of mouse NLRC5 and the tandem 
CARD of mouse RIG-I occurs at a biologically relevant strength under these conditions (data 
not shown). 
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DISCUSSION 
Death-fold domains play a pivotal role in signaling pathways of the immune system and 
cell death pathways, like apoptosis and necroptosis58, 59.  In the last years the structures of 
numerous death-fold domains have been reported. In these studies it was shown that the 
different death-fold subfamilies have a very similar topology in which six α-helices bundle 
around a hydrophobic core in an anti-parallel fashion. Therefore, there is a limited set of 
structural features that differentiates the death-fold domain subfamilies from each other and 
their specific native ligands.  
To provide insight into the immune regulatory function that NLRC5 maintains, we 
determined the solution structure of the mouse NLRC5 atypical CARD using solution NMR 
spectroscopy and performed in vitro interaction studies between NLRC5 and RIG-I. The 
structure of the atypical CARD of mouse NLRC5 resembles the overall fold seen in the death-
fold superfamily, with the conservation of several of the residues involved in the hydrophobic 
core. Internal backbone dynamics, specifically the R2-values and the 15N {1H}-NOE, revealed 
that the atypical CARD of mouse NLRC5 is rigidly folded, except for its flexible N-terminus 
and the loop connecting α-helix 2 and 4, as well as at the C-terminus. These results clearly 
show that the atypical CARD of mouse NLRC5 displays distinct differences in comparison to 
all four death-fold subfamilies. The high sequence similarity suggests that the human ortholog 
exhibits a structure similar to that of the atypical CARD of mouse NLRC5. 
First of all, the atypical CARD of mouse NLRC5 contains a structured loop (α2-α4 loop) 
that does not participate in the hydrophobic core at the position at which α-helix 3 occurs in 
the DED, DD, CARD, and PYD folds. This variation is very similar to the PYD fold, except 
that PYD contains a more flexible loop and a short α-helix 3 that clearly has an orientation 
different from the α2-α4 loop of the mouse NLRC5 atypical CARD.  
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In the DED-fold α-helix 3 is similarly oriented as in the PYD and contains the RxDL-motif, 
which is absent in the atypical CARD of mouse NLRC5. Except for the α2-α4 loop, both the 
DD-and CARD-fold possess strong similarities to the atypical CARD of mouse NLRC5. 
However, when taking the alignment of α-helices 2, 3, and 4 into account, the atypical CARD 
of mouse NLRC5 is in a better agreement with the CARD-fold.  
A more detailed comparison  of the atypical CARD of mouse NLRC5 with the ICEBERG 
CARD, its closest homologue according to the DALI-server, clearly reveals striking 
differences between both folds such as the non-interrupted α-helix 1, the replacement of α-
helix 3 by the α2-α4 loop, the presence of a short α-helix 0 succeeded by a 3 amino acids 
long loop, and the fact that α-helix 6 is attached to α-helix 5 by a unusually extended 6 amino 
acid long loop. Based on these observations, we decided to classify the N-terminal effector 
domain of mouse NLRC5 as an atypical CARD.  
The homotypic DD-DD interaction can be established with three types of interaction modes 
(type I, II and III) modes19, 57. Out of these three possible modes, two have been reported (type 
I and type III) for the homotypic CARD-CARD interaction56, 57. From the interaction between 
the CARDs of Apaf-1/ procaspase-956, RAIDD/caspase 249 and NOD1/RICK7 it is known that 
electrostatic interactions between complementary charged and shaped surfaces provide a tight 
CARD-CARD interaction. The interaction patches involved in these interactions modes are 
comprised of α-helix 1/α-helix4 (patch Ia), α-helix 2/ α-helix 3 (patch Ib), α-helix 3 (patch 
IIIa), and loop α1-α2/loop α3- α4 (patch IIIb).  
It is clear that the unique features of the NLRC5 atypical CARD can strongly influence the 
possible modes of interaction. For instance, it is very likely that the uniquely structured α2-α4 
loop is involved in a type III interaction, which possibly triggers structuring and formation of 
a full α-helix 3.  
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In addition, α-helix 0 and the uninterrupted α-helix 1 may support a type I interaction as 
observed for the CARD-fold. The negatively charged surface patch (residues Glu31, Glu83, 
and Asp85) of the atypical CARD of NLRC5 does not share the shape and location with the 
interaction epitopes involved in the three homotypic death-fold interaction modes. Therefore 
it is clear that the homotypic interaction of NLRC5 atypical CARD with its binding partner 
RIG-I tandem CARD must be different from the previously described homotypic CARD-
CARD interactions.  
Exchange contributions to R2 relaxation rates for residues of helices 1 and 6 and the α5-α6 
loop, which form an extensive hydrophobic surface patch, indicate that these residues likely 
act as a dimerization interface. As NLR proteins are known to oligomerize upon activation, it 
is possible that full-length NLRC5 exhibits auto-oligomerization activity and the site of 
interaction with the native ligand may then be part of the thereby formed surface60. This 
hypothesis is supported by the formation of a negatively charged surface patch upon 
dimerization of the atypical CARD of mouse NLRC5 involving Glu31, Glu83, and Asp85. 
We like to note here that Glu83 is not conserved in other species.  
In contrast to Cui et al., who performed classical co-immunoprecipitation assays in 
HEK293T cells13, our co-immunoprecipitation assays involved the separate expression and 
the lysis of HEK293T cells before combining the putative interaction partners. In this specific 
experimental set-up, using the (mouse and human) atypical CARD of NLRC5 and (mouse 
and human) RIG-I tandem CARD constructs, we demonstrate that both proteins do not 
interact. This result was supported by the absence of chemical shift perturbations in the NMR 
experiments involving the atypical CARD of mouse NLRC5 (1-96) and the tandem CARD of 
mouse RIG-I tandem (1-186). 
Since both proteins interact in the cell, adapter proteins might be required or as for the RIG-
I/MAVS interaction61, RIG-I lysine K63 ubiquitin ligation is required for interaction.  
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This approach indicates that the atypical CARD of mouse NLRC5 and the tandem CARD 
mouse RIG-I might interact through the hydrophobic surface formed by α-helix 1, 6 and the 
α5-α6 loop (data not shown).  
To analyze the interaction between the atypical CARD of NLRC5 and the tandem CARD of 
RIG-I it is important to probe for interactions in cellular systems that allow such 
modifications and provide possible adapter proteins. For in-depth characterization of 
biochemically relevant interactions on  a molecular level methods such as yeast two hybrid or 
tandem mass spectrometry assisted interaction assays using cell extracts might be needed.   
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Table 1. Structural Statistics for the 20 Lowest Energy Structures. 
NMR distance restraints (all)   
Total NOE  1278 (100%) 
Intraresidue (|i-j|=0)  429 (33.6%) 
Sequential (|i-j|=1)  347 (27.2%) 
Short-range (|i-j|≤1)  776 (60.7%) 
Medium-range (1<|i-j|<5)  304 (23.8%) 
Long-range (|i-j|≥5)  198 (15.5%) 
Deviations from idealized geometry 
Bond lengths (Ǻ)  0.016 
Bond angles (°)  1.4 
Ramachandran plot statistics (6-98; NMR-PROCHECK) 
Residues in most favored regions (%) 86.4 
Residues in additionally allowed regions (%) 11.4 
Residues in generally allowed regions (%) 1.1 
Residues in disallowed regions (%) 1.1 
Pairwise RMSD (Å) 
Backbone (N, Cα, C, O)  0.59±0.10 
All Heavy atoms  1.72±0.4 
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Table 2. Superposition of the Atypical CARD of Mouse NLRC5 and Death-fold Domains.   
aThe RMSD and Z-scores were calculated using the DALI server47. bThe aligned Cα depicts 
the amount of residues that could be aligned for this particular structural alignment. The list is 
ordered by decreasing Z-scores. 
  
Protein Domain PDB-id Z-scorea RMSD (Å)a Aligned Cαb 
ICEBERG CARD 1DGN 6.6 2.7 74 
NOD1 CARD 4E9M 6.5 2.5 68 
DARK CARD 1VT4 6.0 2.8 80 
Apaf-1 CARD 1C15 5.7 3.2 77 
Fas DD 3EZQ 5.7 4.3 74 
UNC5H2 DD 1WMG 5.7 2.3 68 
NLRP3 PYD 3QF2 3.4 3.4 72 
NLRP7 PYD 2KM6 4.2 2.9 73 
38 
 
FIGURES 
Figure 1:  The solution structure of the atypical CARD of mouse NLRC5. (A) Ensemble 
of the 20 lowest-energy structures showing residues 6 – 98 in which the α-helices are 
highlighted in orange, the loops in gray. (B) Cartoon representation of the lowest-energy 
conformer of the atypical CARD of mouse NLRC5 presented in stereo view. (C) The 
conserved central hydrophobic core of the atypical CARD of mouse NLRC5 in stereo view. 
The side-chains are shown in sticks and highlighted in green. 
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Figure 2:  Structural comparison of the atypical CARD of mouse NLRC5 with a 
representative of the four death-fold subfamilies. The atypical CARD of mouse NLRC5 is 
shown in a gray ribbon presentation. The representative of the death-fold subfamilies are 
presented in cartoon and in spectrum color. The pairwise RMSD between the atypical CARD 
of NLRC5 and all other death-fold domains was calculated by superposition of Cα atoms of 
α-helices 0/1–6. The orientation of the α2-α4 loop axis (black arrow) is depicted 
schematically in relation to the axis orientation of α-helix 3 (green arrow) of the overlaid 
death-fold domain. The residues in the figure and the schematic drawing indicate the 
boundaries, which were taken for the axis orientation of the α2-α4 loop axis (black) and the 
overlaid death-fold domain (green). (A) Sequence representation of the structural alignments. 
Residues that constitute the hydrophobic core are labeled in green. (B) Structural alignment of 
mouse NLRC5 atypical CARD with the PYD of NLRP7 (PDB: 2KM6; RMSD 3.020 Å). (C) 
Structural alignment of mouse NLRC5 atypical CARD with the DED of PEA-15 (PDB: 
1N3K; RMSD 3.081 Å). (D) Structural alignment of NLRC5 atypical CARD with the DD of 
RAIDD (PDB: 3MOP; RMSD 3.314 Å). (E) Structural alignment of NLRC5 atypical CARD 
with the CARD of ICEBERG (PDB: 1DNG; RMSD 2.165 Å).  
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Figure 3:  Detailed structural comparison of the atypical CARD of mouse NLRC5 with 
ICEBERG-CARD. Cartoon presentation of the atypical CARD of mouse NLRC5 (blue) and 
ICEBERG (gray). (A) NLRC5 atypical CARD α-helix 0 and 1 overlaid with the interrupted 
first α-helix (1a, b) of ICEBERG CARD. (B) NLRC5 atypical CARD α-helix 2 and loop α2-
α4 overlaid with α-helix 2 and α-helix 3 of ICEBERG CARD. (C) NLRC5 atypical CARD 
loop α2-α4 and α-helix 4 overlaid with α-helix 3 and 4 of ICEBERG CARD. (D) The 
atypical CARD of NLRC5 α-helix 5 and 6 overlaid with the α-helix 5 and 6 of ICEBERG 
CARD. 
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Figure 4:  15N backbone dynamics of the atypical CARD of mouse NLRC5. (A)-(C) 15N 
relaxation as measured on a 700 MHz spectrometer at 310K as observed for the 1-96 
construct of the atypical CARD of mouse NLRC5 at concentrations of 600 µM (black circles) 
and 150 µM (red circles). Experimentally derived secondary structure elements of the atypical 
CARD of mouse NLRC5 are depicted on top of the figure. (A) 15N {1H}-NOE as well as the 
(B) R1 and (C) R2 relaxation rates of the atypical NLRC5 CARD. (D)-(G) Motional 
parameter derived from a Modelfree analysis for data from the 600 µM (D,E) and 150 µM 
(F,G) samples. Depicted are the generalized order parameter S2 (D,F) and the exchange 
contribution Rex (E,G). The Modelfree analysis assumed a monomer-dimer equilibrium with 
a Kd of 100 µM and a global correlation time of 4.0 and 3.8 ns for the 600 µM and the 150 
 µM sample respectively. 
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Figure 5:  Surface representation of the atypical CARD of mouse NLRC5. (A) Cartoon 
representation of the atypical CARD of NLRC5 in which the residues that show increased R2 
values as measured in the 15N- auto-correlated backbone dynamics, and thus indicated to be 
involved in a putative dimerization interface, are shown in yellow.  
The residues that are involved in the formation of the putative dimerization of the atypical 
CARD of mouse NLRC5, as indicated by the increased R2 values in the 15N- auto-correlated 
backbone dynamics, are labelled and depicted as sticks. (B) Electrostatic surface 
representation of the atypical CARD of mouse NLRC5 rotated 160° over the Y-axis and 30° 
over the X-axis in comparison to Figure 5A. A positive surface charge is colored blue; a 
negative surface charge is colored red; and a neutral surface is colored white. The residues 
that form the negatively charged patch in the monomeric NLRC5 atypical CARD (Glu31, 
Asp79, Glu83, and Asp85) are labelled.  (C) The dimer of the atypical CARD of NLRC5 in 
cartoon representation as modelled by the ClusPro 2.0 server62. The left presentation of the 
dimer is rotated 90° over the Y-axis in comparison to the monomer in Figure 5A. (D) 
Electrostatic surface representation of the modelled dimer of the atypical CARD of mouse 
NLRC5. The residues that form the negatively charged patch of the dimer (Glu31, Glu83, and 
Asp85) are labelled.  
 
